Integra LifeSciences Announces Completion of Its Multicenter Clinical Trial for the Treatment of Diabetic Foot Ulcers
Go back to Integra LifeSciences Announces Completion of Its Multicenter Clinical Trial for the Treatment of Diabetic Foot Ulcers| Integra LifeSciences Holdings (NASDAQ: IART) | Delayed: 17.77 +0.26 (1.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.51 | 52 Week High | $88.86 | |||
| Open | $17.42 | 52 Week Low | $54.75 | |||
| Day High | $17.88 | P/E | N/A | |||
| Day Low | $17.25 | EPS | $-0.59 | |||
| Volume | 534,402 | |||||
